Diagnostic tests for hepatitis C. (Q33809460)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10622564%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

review article

1 reference

title

Diagnostic tests for hepatitis C (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10622564%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author

Jean-Michel Pawlotsky

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10622564%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Pawlotsky JM

1 reference

29 July 2017

publication date

1 January 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10622564%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10622564%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

31 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10622564%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

71-79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10622564%20AND%20SRC:MED&resulttype=core&format=json

Effects of anticoagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virus

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Impact of specimen handling and storage on detection of hepatitis C virus RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Impact of various handling and storage conditions on quantitative detection of hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Stability of hepatitis C virus RNA during specimen handling and storage prior to NASBA amplification

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Reliability of polymerase chain reaction for detection of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Improvement of hepatitis C virus RNA polymerase chain reaction through a multicentre quality control study. French Study Group for the Standardization of Hepatitis C Virus PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

International collaborative study on the second EUROHEP HCV-RNA reference panel

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

New kit on the block: Evaluation of second-generation assays for detection of antibody to the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Detection of chronic hepatitis C virus infection by four diagnostic systems: first-generation and second-generation enzyme-linked immunosorbent assay, second-generation recombinant immunoblot assay and nested polymerase chain reaction analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Investigation of sera reactive to hepatitis C virus by second-generation enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Detection of Antibody to Hepatitis C Virus by Second-Generation Enzyme Immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Second-generation hepatitis C Elisa antibody tests confirmed by the four-antigen recombinant immunoblot assay correlate well with hepatitis C viremia and chronic liver disease in Swedish blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Evidence that use of a second-generation hepatitis C antibody assay prevents additional cases of transfusion-transmitted hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing hemodialysis: comparison of second- and third-generation anti-HCV assays

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Sensitivity and specificity of three third-generation anti-hepatitis C virus ELISAs

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Increased detection of hepatitis C virus infection in commercial plasma donors by a third-generation screening assay

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Evaluation of a new automated third-generation anti-HCV enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Hepatitis C virus seroconversion by a third generation ELISA screening test in blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Detection of common hepatitis C virus subtypes with a third-generation enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Performance of three generations of anti‐hepatitis C virus enzyme‐ linked immunosorbent assays in donors and patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Significance of NS5-"indeterminate" third-generation anti-hepatitis C virus serologic assays

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: a new marker of HCV infection closely associated with viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Detection of anti-hepatitis C virus antibodies in patients undergoing dialysis by utilizing a hepatitis C virus 3.0 assay: correlation with hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Prevalence of antibody to hepatitis C virus (HCV) in HIV-1-infected patients (nice SEROCO cohort).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. Copenhagen Dialysis HCV Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Serologic responses to hepatitis C virus in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Detection of hepatitis C after liver transplantation. Four serologic tests compared.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Membranoproliferative Glomerulonephritis Associated with Hepatitis C Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

What technique should be used for routine detection and quantification of HBV DNA in clinical samples?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Recombinant immunoblot and polymerase chain reaction testing in volunteer whole blood donors screened by a multi‐antigen assay for hepatitis C virus antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

IgM-antibody response to hepatitis C virus antigens in acute and chronic post-transfusion non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

IgM antibody to hepatitis C virus in acute and chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Immunoglobulin M reactivity towards the immunologically active region sp75 of the core protein of hepatitis C virus (HCV) in chronic HCV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Real-time detection system for quantification of hepatitis C virus genome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Diagnostic tests for hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Quantification of serum hepatitis C virus core protein level in patients chronically infected with different hepatitis C virus genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Preparation and characterization of RNA standards for use in quantitative branched DNA hybridization assays

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Quantification of hepatitis C virus RNA in serum by branched DNA-based signal amplification assays

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Evaluation of Two Methods for Quantitation of Hepatitis C Virus RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Measuring hepatitis C viremia in clinical samples: Can we trust the assays?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Quantification of serum hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

A second-generation method of genotyping hepatitis C virus by the polymerase chain reaction with sense and antisense primers deduced from the core gene

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

A DNA hybridization method for typing hepatitis C virus genotype 2c.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Evaluation of a novel serotyping system for hepatitis C virus: strong correlation with standard genotyping methodologies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Serologically defined genotypes of hepatitis C virus among Japanese patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Serological determination of hepatitis C virus genotype: comparison with a standardized genotyping assay

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Evaluation and comparison of different hepatitis C virus genotyping and serotyping assays

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

A French consensus conference on hepatitis C: screening and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980378-X

7 January 2021

10.1016/S0168-8278(99)80378-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10622564%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10622564%20AND%20SRC:MED&resulttype=core&format=json